Craft
Marinomed

Marinomed

Stock Price

€36.9

2023-03-24

Market Capitalization

€55.6 M

2023-03-24

Marinomed Summary

Company summary

Overview
Marinomed Biotech is a biopharmaceutical company. It specializes in the development of products in the field of respiratory and ophthalmic diseases. The company provides the Carragelose platform treating viral infections of the respiratory tract and the Marinosolv technology platform supporting the efficacy of hardly soluble compounds.
Type
Public
Status
Active
Founded
2006
HQ
Korneuburg, AT | view all locations
Website
https://www.marinomed.com/
Cybersecurity rating
Sectors

Key people

  • Andreas Grassauer

    Andreas Grassauer, Chief Executive Officer

    • Pascal Schmidt

      Pascal Schmidt, Chief Financial Officer

      • Eva Prieschl-Grassauer

        Eva Prieschl-Grassauer, Chief Scientific Officer

        LocationsView all

        1 location detected

        • Korneuburg, Niederösterreich HQ

          Austria

          Hovengasse 25

        Footer menu